1. World Health Organization, WHO-IUTALD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world (report no. 4) [cited 2008 Apr 30]. http://www.who.int/tb/publications/2008/drs_report4_26feb08.pdf
2. Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.;Cox;PLoS ONE,2010
3. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB) 2010. Global report on surveillance and response [cited 2010 Jun 26]. http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf
4. National Health Laboratory Services. National Institute for Communicable Diseases annual report 2009 [cited 2012 Jan 26]. http://www.nicd.ac.za/assets/files/Annual_report_2009.pdf
5. Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992–2002.;Shean;Int J Tuberc Lung Dis,2008